Michele Lanza1, Erica Paolillo2, Ugo Antonello Gironi Carnevale2, Alessandro Lanza2, Carlo Irregolare3, Luigi Mele2, Mario Bifani2. 1. Dipartimento Multidisciplinare di Scienze Mediche, Chirurgiche e Odontoiatriche, Seconda Università di Napoli, Napoli, Italy; Centro Grandi Apparecchiature, Seconda Università di Napoli, Napoli, Italy. Electronic address: mic.lanza@gmail.com. 2. Dipartimento Multidisciplinare di Scienze Mediche, Chirurgiche e Odontoiatriche, Seconda Università di Napoli, Napoli, Italy. 3. Centro Grandi Apparecchiature, Seconda Università di Napoli, Napoli, Italy.
Abstract
PURPOSE: To compare corneal pachymetry values measured by three different optical devices: Orbscan II, Pentacam HR and Sirius in healthy eyes. METHODS: The central corneal thickness (CCT) of 102 eyes of 102 healthy subjects (mean age of 33.09 ± 8.72 years and mean refractive defect -4.11 ± 4.74 D) was measured by three different physicians using Orbscan II, Pentacam HR and Sirius. The normality of the distribution was evaluated by with Kolmogorov-Smirnov test. The correlations between CCT obtained from each device and refractive defect and age were evaluated using the Pearson test. The differences were evaluated by the Student paired t-test using SPSS 18.0 (IBM Corp. Armonk, New York). RESULTS: Orbscan II provided significant (p < 0.0001) lower CCT measurements then both Pentacam HR (-13.66 ± 16.53 μm) and Sirius (-15.18 ± 17.16 μm); Sirius showed values slightly higher than Oculus Pentacam HR (+1.52 ± 6.21 μm) that appeared to be statistically significant (p < 0.015). CONCLUSIONS: The measurement of CCT by Sirius and Pentacam HR provides similar results. By contrast, the results obtained by Orbscan II are different from those obtained from both Sirius and Pentacam HR.
PURPOSE: To compare corneal pachymetry values measured by three different optical devices: Orbscan II, Pentacam HR and Sirius in healthy eyes. METHODS: The central corneal thickness (CCT) of 102 eyes of 102 healthy subjects (mean age of 33.09 ± 8.72 years and mean refractive defect -4.11 ± 4.74 D) was measured by three different physicians using Orbscan II, Pentacam HR and Sirius. The normality of the distribution was evaluated by with Kolmogorov-Smirnov test. The correlations between CCT obtained from each device and refractive defect and age were evaluated using the Pearson test. The differences were evaluated by the Student paired t-test using SPSS 18.0 (IBM Corp. Armonk, New York). RESULTS: Orbscan II provided significant (p < 0.0001) lower CCT measurements then both Pentacam HR (-13.66 ± 16.53 μm) and Sirius (-15.18 ± 17.16 μm); Sirius showed values slightly higher than Oculus Pentacam HR (+1.52 ± 6.21 μm) that appeared to be statistically significant (p < 0.015). CONCLUSIONS: The measurement of CCT by Sirius and Pentacam HR provides similar results. By contrast, the results obtained by Orbscan II are different from those obtained from both Sirius and Pentacam HR.